Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.11.18 (
MAP
)
7,412
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Plants induce systemic acquired resistance (SAR) upon localized exposure to pathogens.
Pipecolic acid
(Pip) production via AGD2-LIKE DEFENSE RESPONSE PROTEIN1 (ALD1) is key for SAR establishment. Here, we report a positive feedback loop important for SAR induction in
Arabidopsis thaliana
We showed that local activation of the
MAP
kinases MPK3 and MPK6 is sufficient to trigger Pip production and mount SAR. Consistent with this, mutations in
MPK3
or
MPK6
led to compromised Pip accumulation upon inoculation with the bacterial pathogen
Pseudomonas syringae
pv
tomato
DC3000 (
Pto
) AvrRpt2, which triggers strong sustained MAPK activation. By contrast,
P. syringae
pv
maculicola
and
Pto
, which induce transient MAPK activation, trigger Pip biosynthesis and SAR independently of MPK3/6.
ALD1
expression, Pip accumulation, and SAR were compromised in mutants defective in the MPK3/6-regulated transcription factor WRKY33. Chromatin immunoprecipitation showed that WRKY33 binds to the
ALD1
promoter. We found that Pip triggers activation of MPK3 and MPK6 and that MAPK activation after
Pto
AvrRpt2 inoculation is compromised in
wrky33
and
ald1
mutants. Collectively, our results reveal a positive regulatory loop consisting of MPK3/MPK6, WRKY33, ALD1, and Pip in SAR induction and suggest the existence of distinct SAR activation pathways that converge at the level of Pip biosynthesis.
...
PMID:A MPK3/6-WRKY33-ALD1-Pipecolic Acid Regulatory Loop Contributes to Systemic Acquired Resistance. 3022 26